Hall Capital Management CO Inc Gilead Sciences, Inc. Transaction History

Hall Capital Management CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 02, 2021	SELL	$56.65 - $64.55 $194,252 - $221,341	-3,429 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $1.19 Million - $1.49 Million	-19,109 Reduced 84.79%	3,429 $217,000
Q2 2020 Nov 16, 2020	BUY	$72.34 - $84.0 $939,334 - $1.09 Million	12,985 Added 135.93%	22,538 $1.73 Million
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $598,304 - $766,341	9,553 New	9,553 $714,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hall Capital Management CO Inc, based on Form 13F filings with the SEC.

Stay updated on Hall Capital Management CO Inc with notifications on news.